MedTrace Logo

Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels

NCT00284011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2012-01-06

No results posted yet for this study

Summary

The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

SAMe

800 mg dose daily for 4 weeks.

OTHER

Placebo

2 placebo pills daily for 4 weeks.

Sponsors & Collaborators

Principal Investigators

  • Dietland Wahner-Roedler, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2006-04-30
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284011 on ClinicalTrials.gov